pyrimidine nucleosides

Preferred Label : pyrimidine nucleosides;

MeSH definition : Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.;

MeSH synonym : nucleosides, pyrimidine;

Is substance : O;

Détails

Origin ID

D011741;

UMLS CUI

C0034287;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Pyrimidine nucleoside (substance) [SNOMED CT concept]
Record concept(s)
- pyrimidine nucleosides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (5-(4-amino-6-bromo-5-carbamoyl-1H-pyrrolo(2,3-d)pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate [MeSH Supplementary Concept]
- 1-((1,2,3,4)-2-fluoro-3-hydroxy-4-( hydroxymethyl)cyclopentyl)-5-iodo-2,4(1H,3H)-pyrimidinedione [MeSH Supplementary Concept]
- 1-((1,2,3,4)-2-fluoro-3-hydroxy-4-(hydroxymethyl)cyclopentyl)-5-methyl-2,4-(1H,3H)-pyrimidinedione [MeSH Supplementary Concept]
- 1-(2',3'-dideoxy-3'(hydroxymethyl)erythropentofuranosyl)cytosine [MeSH Supplementary Concept]
- 1-(2'-deoxyribosyl)-2-pyrimidinone [MeSH Supplementary Concept]
- 1-(2-(hydroxymethyl)-1,3-dioxolan-4-yl)5-vinylpyrimidine-2,4(1H,3H)-dione [MeSH Supplementary Concept]
- 1-(2-deoxy-beta-ribofuranosyl)-5-bromo-2-pyrimidinone [MeSH Supplementary Concept]
- 1-(3-fluoro-4-hydroxy-5-mercaptomethyltetrahydrofuran-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [MeSH Supplementary Concept]
- 1-(4-O-benzyl-1,5-anhydro-2,3-dideoxy-arabino-hex-1-enitol-3-yl)-4-methoxy-1H-pyrimidin-2-one [MeSH Supplementary Concept]
- 1-(beta-ribofuranosyl)furo(3,4-d)pyrimidine-2,4,7(1H,3H,5H)-trione [MeSH Supplementary Concept]
- 1-(erythro-pentofuranosyl)-4-pentafluorophenyloxy-2(1H)pyrimidinone [MeSH Supplementary Concept]
- 1-ribofuranosylpyridin-2-one-5-carboxamide [MeSH Supplementary Concept]
- 1100 50 compound [MeSH Supplementary Concept]
- 2',3'-didehydro-3'-deoxy-4-thiothymidine [MeSH Supplementary Concept]
- 2'-arafluorozebularine [MeSH Supplementary Concept]
- 2'-deoxysangivamycin [MeSH Supplementary Concept]
- 2,4-di-(1,2,4-triazol-1-yl)-5-(2,3,5-tri-O-acetylribofuranosyl)pyrimidine [MeSH Supplementary Concept]
- 2,4-diamino-5-(2'-deoxyribofuranosyl)pyrimidine [MeSH Supplementary Concept]
- 2,5-diamino-4-hydroxy-6-(2'-deoxyribosyl)-formamidopyrimidine [MeSH Supplementary Concept]
- 3'-deoxy-4-thiothymidine [MeSH Supplementary Concept]
- 3'-deoxysangivamycin [MeSH Supplementary Concept]
- 3-(2'-deoxyribofuranosyl)-6-(3-fluoroethoxyphenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2-one [MeSH Supplementary Concept]
- 3-(2'-deoxyribofuranosyl)-6-(3-methoxyphenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2-one [MeSH Supplementary Concept]
- 3-(2'-deoxyribofuranosyl)-6-(4-(1-fluoroethoxy)phenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2(3H)-one [MeSH Supplementary Concept]
- 3-(2'-deoxyribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro(2,3-d)pyrimidin-2(3H)-one [MeSH Supplementary Concept]
- 3-(2-deoxypentofuranosyl)furo(2,3-d)pyrimidin-2(3H)-one [MeSH Supplementary Concept]
- 3-(2-deoxypentofuranosyl)pyrido(2,3-d)pyrimidine-2,7(8H)-dione [MeSH Supplementary Concept]
- 3-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-6-(4-pentylphenyl)furo(2,3-d)pyrimidin-2(3H)-one [MeSH Supplementary Concept]
- 3-beta-ribofuranosylthieno(2,3-d)pyrimidin-4-one [MeSH Supplementary Concept]
- 3-ribofuranosyl-pyrimido(1,2-a)purin-10(3H)-one [MeSH Supplementary Concept]
- 3-ribofuranosylfuro(2,3-d)pyrimidin-2(3H)-one [MeSH Supplementary Concept]
- 4-amino-1-(1-fluoro-3,4-dihydroxy-2-hydroxymethylcyclohexen-5-yl)-2(1H)-pyrimidinone [MeSH Supplementary Concept]
- 4-amino-6-bromo-1-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo(2,3-d)pyrimidine-5-carboxamide [MeSH Supplementary Concept]
- 4-furfurylamino-7-(beta-D-ribofuranosyl)pyrrolo(2,3-d)-pyrimidine [MeSH Supplementary Concept]
- 4-methoxy-8-(ribofuranosylamino)pyrimido(5,4-d)pyrimidine [MeSH Supplementary Concept]
- 5'-O-benzoyl-3'-deoxythymidine [MeSH Supplementary Concept]
- 5'-deoxy-5'-amino-clitocine [MeSH Supplementary Concept]
- 5-(2-amino-3-cyano-5-oxo-5,6,7,8-tetrahydro-4H-chromen-4-yl)-1-(2-deoxypentofuranosyl)pyrimidine-2,4-(1H,3H)-dione [MeSH Supplementary Concept]
- 5-amino-2,4-dioxy-6-ribitylaminopyrimidine [MeSH Supplementary Concept]
- 5-amino-3-(2-deoxypentofuranosyl)thiazolo(4,5-d)pyrimidine-2,7-3H,6H-dione [MeSH Supplementary Concept]
- 5-ethyluracil-1-beta-D-galactopyranoside [MeSH Supplementary Concept]
- 5-ethyluracil-1-beta-D-xylopyranoside [MeSH Supplementary Concept]
- 5-fluoropyrimidin-2-one beta-ribofuranoside [MeSH Supplementary Concept]
- 5-fluorouracil glucuronide [MeSH Supplementary Concept]
- 5-methylpyrimidine-2-one 2'-deoxyribonucleoside [MeSH Supplementary Concept]
- FV-100 [MeSH Supplementary Concept]
- N(gamma)-(octyl)glutaminyl-uracil polyoxin C [MeSH Supplementary Concept]
- N,N'-dibenzyl-2,4-diaminopyrimidine-2'-deoxyribonucleoside [MeSH Supplementary Concept]
- N-epsilon-(octanoyl)lysyl-uracil polyoxin C [MeSH Supplementary Concept]
- NSC 105,826 [MeSH Supplementary Concept]
- NSC 283867 [MeSH Supplementary Concept]
- SF 2457 [MeSH Supplementary Concept]
- TI 79 [MeSH Supplementary Concept]
- acyclic pyrazolo(3,4-d)pyrimidine nucleoside [MeSH Supplementary Concept]
- amicetin [MeSH Supplementary Concept]
- ara-sangivamycin [MeSH Supplementary Concept]
- bagougeramine A [MeSH Supplementary Concept]
- bagougeramine B [MeSH Supplementary Concept]
- cf 1698 [MeSH Supplementary Concept]
- cf 1712 [MeSH Supplementary Concept]
- cf 1743 [MeSH Supplementary Concept]
- clitocine [MeSH Supplementary Concept]
- dihydropacidamycin D [MeSH Supplementary Concept]
- gougerotin [MeSH Supplementary Concept]
- isoxazolidinyl deoxypolyoxin C [MeSH Supplementary Concept]
- lysidine [MeSH Supplementary Concept]
- methyl 1-(5-fluoro-1H-2-oxopyrimidin-4-yl)-beta-D- glucopyranuronate [MeSH Supplementary Concept]
- norplicacetin [MeSH Supplementary Concept]
- oxamicetin [MeSH Supplementary Concept]
- pacidamycin 1 [MeSH Supplementary Concept]
- pacidamycin 2 [MeSH Supplementary Concept]
- pacidamycin 3 [MeSH Supplementary Concept]
- pacidamycin 5 [MeSH Supplementary Concept]
- pacidamycin D [MeSH Supplementary Concept]
- pentopyranic acid [MeSH Supplementary Concept]
- pentopyranine A [MeSH Supplementary Concept]
- phosphapyrimidine ribonucleoside 1 [MeSH Supplementary Concept]
- phosphonoxin B1 [MeSH Supplementary Concept]
- phosphonoxin B2 [MeSH Supplementary Concept]
- polyoxin [MeSH Supplementary Concept]
- polyoxin A [MeSH Supplementary Concept]
- polyoxin L [MeSH Supplementary Concept]
- polyoxin O [MeSH Supplementary Concept]
- polyoxin P [MeSH Supplementary Concept]
- polyoxorim [MeSH Supplementary Concept]
- pseudothymidine [MeSH Supplementary Concept]
- pyrimido(4,5-d)pyrimidine-2,4,5,7-(1H,3H,6H,8H)-tetraone ribonucleoside [MeSH Supplementary Concept]
- ropidoxuridine [MeSH Supplementary Concept]
- sangivamycin [MeSH Supplementary Concept]
- streptovirudin [MeSH Supplementary Concept]
- uracil polyoxin C [MeSH Supplementary Concept]
- valopicitabine [MeSH Supplementary Concept]
- yunnanmycin [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
UMLS correspondences (same concept)
- Pyrimidine nucleoside (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients